Axa’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.6M | Buy |
456,666
+371
| +0.1% | +$13.5K | 0.05% | 310 |
|
|
2025
Q1 | $16.5M | Sell |
456,295
-293
| -0.1% | -$10.6K | 0.05% | 303 |
|
|
2024
Q4 | $19.2M | Buy |
456,588
+31,198
| +7% | +$1.31M | 0.06% | 283 |
|
|
2024
Q3 | $23.6M | Buy |
425,390
+56
| +0% | +$3.11K | 0.07% | 247 |
|
|
2024
Q2 | $17.5M | Buy |
425,334
+92,567
| +28% | +$3.8M | 0.05% | 289 |
|
|
2024
Q1 | $15.5M | Buy |
332,767
+55
| +0% | +$2.57K | 0.05% | 324 |
|
|
2023
Q4 | $15.9M | Sell |
332,712
-11,787
| -3% | -$564K | 0.05% | 311 |
|
|
2023
Q3 | $12.3M | Sell |
344,499
-721
| -0.2% | -$25.7K | 0.04% | 358 |
|
|
2023
Q2 | $15.9M | Buy |
345,220
+24,199
| +8% | +$1.12M | 0.05% | 323 |
|
|
2023
Q1 | $12.9M | Sell |
321,021
-412
| -0.1% | -$16.5K | 0.04% | 367 |
|
|
2022
Q4 | $14.9M | Sell |
321,433
-966
| -0.3% | -$44.8K | 0.05% | 357 |
|
|
2022
Q3 | $13.4M | Buy |
322,399
+96,761
| +43% | +$4.01M | 0.05% | 369 |
|
|
2022
Q2 | $13.5M | Sell |
225,638
-2,415
| -1% | -$144K | 0.05% | 374 |
|
|
2022
Q1 | $16.6M | Sell |
228,053
-1,716
| -0.7% | -$125K | 0.05% | 394 |
|
|
2021
Q4 | $19.3M | Buy |
229,769
+11,056
| +5% | +$930K | 0.05% | 366 |
|
|
2021
Q3 | $19.7M | Buy |
218,713
+29,735
| +16% | +$2.68M | 0.06% | 338 |
|
|
2021
Q2 | $18M | Buy |
188,978
+44,223
| +31% | +$4.22M | 0.05% | 376 |
|
|
2021
Q1 | $16.5M | Sell |
144,755
-18,519
| -11% | -$2.11M | 0.05% | 394 |
|
|
2020
Q4 | $22.6M | Sell |
163,274
-63,323
| -28% | -$8.77M | 0.07% | 305 |
|
|
2020
Q3 | $18.6M | Sell |
226,597
-511
| -0.2% | -$42K | 0.07% | 301 |
|
|
2020
Q2 | $17.8M | Sell |
227,108
-69,509
| -23% | -$5.44M | 0.07% | 291 |
|
|
2020
Q1 | $13.2M | Sell |
296,617
-73,145
| -20% | -$3.25M | 0.07% | 301 |
|
|
2019
Q4 | $15.8M | Buy |
369,762
+40,407
| +12% | +$1.73M | 0.06% | 345 |
|
|
2019
Q3 | $14.1M | Buy |
329,355
+32,364
| +11% | +$1.38M | 0.06% | 375 |
|
|
2019
Q2 | $18.9M | Buy |
296,991
+3,601
| +1% | +$229K | 0.07% | 314 |
|
|
2019
Q1 | $20.4M | Buy |
293,390
+117,365
| +67% | +$8.14M | 0.08% | 301 |
|
|
2018
Q4 | $7.65M | Buy |
176,025
+81,242
| +86% | +$3.53M | 0.03% | 490 |
|
|
2018
Q3 | $7.24M | Sell |
94,783
-102,720
| -52% | -$7.84M | 0.03% | 567 |
|
|
2018
Q2 | $15.2M | Sell |
197,503
-66,612
| -25% | -$5.12M | 0.06% | 339 |
|
|
2018
Q1 | $13.5M | Sell |
264,115
-1,905
| -0.7% | -$97.1K | 0.05% | 366 |
|
|
2017
Q4 | $12.3M | Buy |
266,020
+612
| +0.2% | +$28.4K | 0.05% | 399 |
|
|
2017
Q3 | $14.1M | Buy |
265,408
+28,755
| +12% | +$1.53M | 0.06% | 345 |
|
|
2017
Q2 | $14.7M | Buy |
236,653
+70,968
| +43% | +$4.41M | 0.07% | 332 |
|
|
2017
Q1 | $11.2M | Sell |
165,685
-70,782
| -30% | -$4.8M | 0.05% | 387 |
|
|
2016
Q4 | $16.6M | Buy |
236,467
+2,898
| +1% | +$204K | 0.08% | 288 |
|
|
2016
Q3 | $16.6M | Buy |
233,569
+6,356
| +3% | +$451K | 0.07% | 288 |
|
|
2016
Q2 | $11.1M | Sell |
227,213
-19,786
| -8% | -$968K | 0.05% | 366 |
|
|
2016
Q1 | $15.6M | Sell |
246,999
-2,949
| -1% | -$187K | 0.07% | 307 |
|
|
2015
Q4 | $28M | Buy |
249,948
+118,750
| +91% | +$13.3M | 0.12% | 217 |
|
|
2015
Q3 | $12.6M | Buy |
131,198
+15,546
| +13% | +$1.5M | 0.05% | 325 |
|
|
2015
Q2 | $11.8M | Buy |
115,652
+676
| +0.6% | +$69.2K | 0.05% | 383 |
|
|
2015
Q1 | $7.14M | Buy |
114,976
+52,766
| +85% | +$3.28M | 0.03% | 485 |
|
|
2014
Q4 | $2.73M | Buy |
62,210
+199
| +0.3% | +$8.73K | 0.01% | 714 |
|
|
2014
Q3 | $3.51M | Buy |
62,011
+41,159
| +197% | +$2.33M | 0.02% | 612 |
|
|
2014
Q2 | $936K | Hold |
20,852
| – | – | ﹤0.01% | 951 |
|
|
2014
Q1 | $1.02M | Buy |
+20,852
| New | +$1.02M | ﹤0.01% | 917 |
|